The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors

Structure
S M CutfieldJ F Cutfield

Abstract

Infections caused by Candida albicans, a common fungal pathogen of humans, are increasing in incidence, necessitating development of new therapeutic drugs. Secreted aspartic proteinase (SAP) activity is considered an important virulence factor in these infections and might offer a suitable target for drug design. Amongst the various SAP isozymes, the SAP2 gene product is the major form expressed in a number of C. albicans strains. The three-dimensional structures of SAP2 complexed with the tight-binding inhibitor A70450 (a synthetic hexapeptide analogue) and with the general aspartic proteinase inhibitor pepstatin A (a microbial natural product) have been determined to 2.1 A and 3.0 A resolution, respectively. Although the protein structure retains the main features of a typical aspartic proteinase, it also shows some significant differences, due mainly to several sequence insertions and deletions (as revealed by homology modelling), that alter the shape of the binding cleft. There is also considerable variation in the C-terminal structural domain. The differences in side chains, and in the conformations adopted by the two inhibitors, particularly at their P4, P3 and P'2 positions (using standard notation for protease-inhibitor...Continue Reading

References

May 25, 1977·Journal of Molecular Biology·F C BernsteinM Tasumi
Aug 1, 1992·Acta Crystallographica. Section B, Structural Science·L ChenC Abad-Zapatero
Jan 1, 1992·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·R RüchelG T Cole
Feb 1, 1992·Proteins·A SaliT L Blundell
Jan 1, 1991·Annual Review of Microbiology·J E Cutler
Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Jan 1, 1990·Annual Review of Biophysics and Biophysical Chemistry·D R Davies
Jan 1, 1988·Critical Reviews in Biotechnology·L J Douglas
Apr 20, 1967·Biochemical and Biophysical Research Communications·I Schechter, A Berger
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M N JamesT Hofmann
Dec 9, 1994·Science·S Sternberg
Nov 1, 1994·Protein Science : a Publication of the Protein Society·D Bailey, J B Cooper
Jul 1, 1994·Molecular Microbiology·M MonodD Sanglard
Sep 1, 1994·Journal of the American Academy of Dermatology·F C Odds
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E T BaldwinJ W Erickson
Feb 1, 1993·Trends in Genetics : TIG·D R SollT Srikantha
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Jan 1, 1993·Acta Crystallographica. Section D, Biological Crystallography·A T Brünger
Jan 1, 1993·Acta Crystallographica. Section D, Biological Crystallography·K D Cowtan, P Main

❮ Previous
Next ❯

Citations

May 6, 1998·Protein Science : a Publication of the Protein Society·A R Khan, M N James
Oct 10, 2002·Biochemical and Biophysical Research Communications·Damiano Skrbec, Domenico Romeo
Sep 27, 2000·Biochimica Et Biophysica Acta·G KoelschX Lin
Aug 28, 1998·Research in Immunology·R Matthews, J Burnie
Feb 13, 2001·International Journal of Antimicrobial Agents·J BastertE G Evans
Feb 12, 2002·Bioorganic & Medicinal Chemistry·S K Pranav Kumar, Vithal M Kulkarni
Apr 2, 2008·The Journal of Biological Chemistry·Daisuke ImamuraLee Kroos
Nov 5, 1999·Protein Science : a Publication of the Protein Society·N NaganoJ M Thornton
Sep 6, 2008·Microbiology and Molecular Biology Reviews : MMBR·W LaJean Chaffin
Sep 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Julian R NaglikBernhard Hube
Feb 26, 2010·World Journal of Biological Chemistry·André Luis Souza Dos Santos
Oct 2, 2014·Applied Microbiology and Biotechnology·Louwrens W Theron, Benoit Divol
Apr 30, 2009·Journal of Structural Biology·Jirí DostálPavlína Rezácová
Dec 3, 2015·Acta Crystallographica. Section D, Biological Crystallography·Jiří DostálJiří Brynda
Sep 2, 2004·Cellular Microbiology·Julian NaglikBernhard Hube
Nov 3, 2005·Mycoses·Martin SchallerBernhard Hube
Aug 5, 2014·Trends in Microbiology·Alistair J P BrownNeil A R Gow
Oct 18, 2006·FEMS Yeast Research·Michaela MerkerováOlga Hrusková-Heidingsfeldová
Jan 27, 2018·Journal of Fungi·Małgorzata BondarykZofia Urbańczyk-Lipkowska
Nov 20, 1997·The Journal of Biological Chemistry·G Newport, N Agabian
May 4, 2011·World Journal of Biological Chemistry·André Luis Souza Dos Santos
Oct 25, 2000·Protein Science : a Publication of the Protein Society·K StrisovskyH G Kräusslich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.